Delivery systems and technologies have a huge impact on the efficacious dose of clinically validated ingredients.  In this episode, Sebastian Balcombe, CEO of Specnova, joins Devon and Todd for a discussion on liposomal technology and other encapsulation methods such as beadletting and utilizing cyclodextrins.  Utilizing these delivery technologies helps improve the bioavailability and benefits of active ingredients.  They also help with the solubility, taste, and usage level, allowing these beneficial ingredients to be used in more applications.